Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

Cannara Biotech Stock News

LOVFFOTCQB

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$1.01

0.022.02%

At close: -

Cannara Biotech (LOVFF) Forecast

News

Earnings Cannara Biotech (LOVFF) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest Cannara Biotech Stock News | OTC:LOVFF | Benzinga

Get the latest news on Cannara Biotech stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Cannara Biotech performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Wednesday, March 05, 2025

Watching Cannabis Stocks; Marijuana Moment Re...
Benzinga Newsdesk - Mar 5, 2025, 12:38PM

Wednesday, January 15, 2025

FDA Solicits Public Comments On Use Of Cannab...
Benzinga Newsdesk - Jan 15, 2025, 9:04AM

Wednesday, December 11, 2024

Dropbox shares are trading higher after the c...
Benzinga Newsdesk - Dec 11, 2024, 9:25AM

Thursday, December 05, 2024

Are You Missing Out On This NASDAQ-Listed Weed Stock? Low-Cost Model Meets European Demand
Nicolás Jose Rodriguez - Dec 5, 2024, 11:41AM

Wednesday, December 04, 2024

Decibel Cannabis: One Acquisition Could Be The Key To Unlocking $20M In Cash Flow
Nicolás Jose Rodriguez - Dec 4, 2024, 1:34PM

Monday, November 25, 2024

Canadian Cannabis Producer Cannara Reports 43% YoY Revenue Growth, Boosts Market Share And Profitability
Jelena Martinovic - Nov 25, 2024, 11:57AM

Wednesday, November 06, 2024

AP Reports Florida Voters Reject Cannabis Leg...
Benzinga Newsdesk - Nov 5, 2024, 8:44PM

Wednesday, October 30, 2024

Microsoft shares are trading higher after the...
Benzinga Newsdesk - Oct 30, 2024, 4:05PM

Tuesday, October 29, 2024

Canada's Cannabis Market Goes Cold, Pot Prices Hit Bottom: Why Top Producers Are Losing Ground
Nicolás Jose Rodriguez - Oct 29, 2024, 9:29AM

Tuesday, July 23, 2024

Cannara Biotech Reports 6% YoY Drop In Q3 Gross Profit, 22% Revenue Increase As It Enhances Sales Force And Infrastructure
Jelena Martinovic - Jul 23, 2024, 2:06PM

Monday, June 03, 2024

Cannabis Slowdown In Canada: Analyst Spotlights What Still Sells And Where The Money Is Going
Nicolás Jose Rodriguez - Jun 3, 2024, 5:00PM

Wednesday, May 01, 2024

Cannara Biotech Reports 51% YoY Revenue Increase In Q2, Wider Net Loss
Jelena Martinovic - May 1, 2024, 3:45PM

Wednesday, February 07, 2024

Cannara Biotech Q1 Results: Revenue, Net Income And Market Share Up, Quarter Also Marks Company's First Export Sale
Meg Flippin - Sponsored

Tuesday, December 12, 2023

Cannara Biotech Market Share Gains Result In Record-Setting Fourth Quarter
Meg Flippin - Sponsored

Thursday, December 07, 2023

This Cannabis Producer Reports It Is Able to Deliver Some Of The Highest Quality Product To Market At Some Of The Most Competitive Prices
Johnny Rice - Dec 7, 2023, 1:47PM

Monday, August 21, 2023

Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 21, 2023
Benzinga Insights - Aug 21, 2023, 5:30PM

Thursday, August 10, 2023

Cannabis Stock Movers For August 10, 2023
Benzinga Insights - Aug 10, 2023, 5:30PM

Friday, August 04, 2023

Cannabis Stock Gainers And Losers From August 4, 2023
Benzinga Insights - Aug 4, 2023, 5:30PM

Tuesday, August 01, 2023

Marijuana Stock Movers For August 1, 2023
Benzinga Insights - Aug 1, 2023, 5:30PM

Thursday, July 27, 2023

Cannabis Stock Movers For July 27, 2023
Benzinga Insights - Jul 27, 2023, 5:30PM
Cannara Biotech Q3 FY23 Net Revenue Grows 57% YoY, What About Adjusted EBITDA?
Vuk Zdinjak - Jul 27, 2023, 9:09AM

Tuesday, July 25, 2023

Cannabis Stock Gainers And Losers From July 25, 2023
Benzinga Insights - Jul 25, 2023, 5:30PM

Thursday, May 04, 2023

Cannara Biotech Secures An Additional $10M In Non-Dilutive Capital With Its Lead Credit Provider, BMO Commercial Banking
Vuk Zdinjak - May 4, 2023, 10:15AM

Monday, April 24, 2023

Cannara Biotech Q2 FY23 Revenue Grows 76% YoY To $9.6M, Here Are The Details
Vuk Zdinjak - Apr 24, 2023, 9:06AM

Friday, February 10, 2023

Olymbec Investments Increases Its Ownership In Cannara Biotech
Vuk Zdinjak - Feb 10, 2023, 9:12AM

Monday, January 23, 2023

Cannara Biotech Q1 Revenue Grows 57% YoY To $7.7M, What About Adjusted EBITDA?
Vuk Zdinjak - Jan 23, 2023, 8:59AM

Monday, November 28, 2022

Cannara Biotech Q4 Revenue Grows 84% YoY To $8.9M
Vuk Zdinjak - Nov 28, 2022, 10:16AM

Tuesday, September 20, 2022

Cannara Biotech Enters Into The British Columbia Cannabis Market And Launches New Products
Vuk Zdinjak - Sep 20, 2022, 10:02AM

Wednesday, August 03, 2022

Cannara Biotech Signs An Exclusive Brand Partnership With Exotic Genetix In Canada
Vuk Zdinjak - Aug 3, 2022, 10:36AM

Wednesday, July 27, 2022

Cannara Biotech Revenue Grows 41% YoY, Here Are The Details
Vuk Zdinjak - Jul 27, 2022, 9:06AM

Thursday, June 02, 2022

Cannara Biotech Closes $50 Million Credit Facility Led By BMO Commercial Banking
Vuk Zdinjak - Jun 2, 2022, 9:00AM

Wednesday, April 27, 2022

Cannara Biotech Revenues Grew 229% To $7.4M In Q2 2022 YoY
Vuk Zdinjak - Apr 27, 2022, 1:44PM

Tuesday, February 01, 2022

New Kids On The Block: Is A Second Wave Of Canadian Cannabis Here?
Johnny Rice - Sponsored

Saturday, January 22, 2022

What Was In Cannara Biotech's Q1 Earnings Report?
Javier Hasse - Jan 22, 2022, 12:54PM

Friday, December 10, 2021

The Week In Cannabis: Isiah Thomas, Tilray, The DEA, Ohio, Mexico And More
Javier Hasse - Dec 10, 2021, 3:04PM

Thursday, December 09, 2021

Cannara Biotech Shares Surge On 983% QoQ Revenue Growth, Positive Adjusted EBITDA
Nina Zdinjak - Dec 9, 2021, 9:16AM

Monday, August 02, 2021

Tilray Best Performer Among Canadian Cannabis LPs, Stocks Plunge Nearly 10% In July
Jelena Martinovic - Aug 2, 2021, 1:34PM

Thursday, July 29, 2021

Cannara Biotech Cannabis Co. Slightly Beats Estimates, Posts $7.2M In Q3 2021 Revenue
Jelena Martinovic - Jul 29, 2021, 2:22PM

Friday, July 02, 2021

The Week In Cannabis: Justice Clarence Thomas, Mexico's Decriminalization, Apple's Policy Changes, Tilray And More
Javier Hasse - Jul 2, 2021, 5:09PM

Monday, June 28, 2021

Cannara Biotech Cannabis Co. Expects To Post $7.1M In Q3 Revenue After Successful Market Launch In Quebec
Jelena Martinovic - Jun 28, 2021, 2:03PM

Friday, April 17, 2020

Cannabis Earnings Roundup: Avicanna, Cannara Biotech, Halo Labs
Nina Zdinjak - Apr 17, 2020, 10:49AM

Friday, February 21, 2020

FSD Pharma Sells Cannara Biotech Stake, Netting More Than $7.7M
Javier Hasse - Feb 21, 2020, 12:20PM

Friday, August 16, 2019

Stocks That Hit 52-Week Highs On Friday
Lisa Levin - Aug 16, 2019, 10:35AM

Thursday, August 15, 2019

Stocks That Hit 52-Week Highs On Thursday
Lisa Levin - Aug 15, 2019, 11:17AM

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved